BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 26308893)

  • 1. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity.
    Waclaw B; Bozic I; Pittman ME; Hruban RH; Vogelstein B; Nowak MA
    Nature; 2015 Sep; 525(7568):261-4. PubMed ID: 26308893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour heterogeneity and resistance to cancer therapies.
    Dagogo-Jack I; Shaw AT
    Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial and temporal cancer evolution: causes and consequences of tumour diversity.
    Hiley CT; Swanton C
    Clin Med (Lond); 2014 Dec; 14 Suppl 6():s33-7. PubMed ID: 25468916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Range Expansion Theories Could Shed Light on the Spatial Structure of Intra-tumour Heterogeneity.
    Gidoin C; Peischl S
    Bull Math Biol; 2019 Nov; 81(11):4761-4777. PubMed ID: 30535848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer development and progression: a non-adaptive process driven by genetic drift.
    Aranda-Anzaldo A
    Acta Biotheor; 2001; 49(2):89-108. PubMed ID: 11450810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.
    Murtaza M; Dawson SJ; Tsui DW; Gale D; Forshew T; Piskorz AM; Parkinson C; Chin SF; Kingsbury Z; Wong AS; Marass F; Humphray S; Hadfield J; Bentley D; Chin TM; Brenton JD; Caldas C; Rosenfeld N
    Nature; 2013 May; 497(7447):108-12. PubMed ID: 23563269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation.
    Pongor L; Harami-Papp H; Méhes E; Czirók A; Győrffy B
    Sci Rep; 2017 Aug; 7(1):7358. PubMed ID: 28779157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constraints in cancer evolution.
    Venkatesan S; Birkbak NJ; Swanton C
    Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.
    de Maar JS; Sofias AM; Porta Siegel T; Vreeken RJ; Moonen C; Bos C; Deckers R
    Theranostics; 2020; 10(4):1884-1909. PubMed ID: 32042343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model.
    Powathil GG; Gordon KE; Hill LA; Chaplain MA
    J Theor Biol; 2012 Sep; 308():1-19. PubMed ID: 22659352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation.
    Ohsawa S; Takemoto D; Igaki T
    J Biochem; 2014 Sep; 156(3):129-36. PubMed ID: 25012819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural selection: The evolution of cancer.
    Goymer P
    Nature; 2008 Aug; 454(7208):1046-8. PubMed ID: 18756229
    [No Abstract]   [Full Text] [Related]  

  • 13. Population genetics of cancer cell clones: possible implications of cancer stem cells.
    Naugler CT
    Theor Biol Med Model; 2010 Nov; 7():42. PubMed ID: 21062473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exactly solvable, spatial model of mutation accumulation in cancer.
    Paterson C; Nowak MA; Waclaw B
    Sci Rep; 2016 Dec; 6():39511. PubMed ID: 28004754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour heterogeneity and the evolution of polyclonal drug resistance.
    Burrell RA; Swanton C
    Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation-selection balance and compensatory mechanisms in tumour evolution.
    Persi E; Wolf YI; Horn D; Ruppin E; Demichelis F; Gatenby RA; Gillies RJ; Koonin EV
    Nat Rev Genet; 2021 Apr; 22(4):251-262. PubMed ID: 33257848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer: A moving target.
    Komarova NL
    Nature; 2015 Sep; 525(7568):198-9. PubMed ID: 26308890
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigating intratumour heterogeneity by single-cell sequencing.
    Ren SC; Qu M; Sun YH
    Asian J Androl; 2013 Nov; 15(6):729-34. PubMed ID: 24141534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatially constrained tumour growth affects the patterns of clonal selection and neutral drift in cancer genomic data.
    Chkhaidze K; Heide T; Werner B; Williams MJ; Huang W; Caravagna G; Graham TA; Sottoriva A
    PLoS Comput Biol; 2019 Jul; 15(7):e1007243. PubMed ID: 31356595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.